Organo Corp
TSE:6368
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
5 540
9 330
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Organo Corp
Organo Corp
Income from Continuing Operations
Organo Corp
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Organo Corp
TSE:6368
|
Income from Continuing Operations
¥19.9B
|
CAGR 3-Years
37%
|
CAGR 5-Years
23%
|
CAGR 10-Years
57%
|
|
|
Mitsubishi Heavy Industries Ltd
TSE:7011
|
Income from Continuing Operations
¥254.9B
|
CAGR 3-Years
29%
|
CAGR 5-Years
13%
|
CAGR 10-Years
3%
|
|
|
IHI Corp
TSE:7013
|
Income from Continuing Operations
¥111.7B
|
CAGR 3-Years
48%
|
CAGR 5-Years
58%
|
CAGR 10-Years
10%
|
|
|
SMC Corp
TSE:6273
|
Income from Continuing Operations
¥161.9B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
8%
|
CAGR 10-Years
5%
|
|
|
Makita Corp
TSE:6586
|
Income from Continuing Operations
¥61.1B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
|
Fanuc Corp
TSE:6954
|
Income from Continuing Operations
¥142.2B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-1%
|
|
Organo Corp
Glance View
In the bustling heart of the environmental solutions industry sits Organo Corp., a dynamic company pioneering the development of water treatment and purification systems. Founded with the vision of transforming how industries handle water resources, Organo has become synonymous with innovation and sustainability. At its core, the company designs, manufactures, and maintains advanced water treatment systems tailored for industrial clients across various sectors, from power generation to semiconductors and beyond. These systems are engineered to meet stringent regulatory standards while optimizing water reuse and minimizing waste, underscoring Organo's commitment to ecological stewardship. The company’s portfolio extends beyond hardware solutions; it also encompasses cutting-edge monitoring technologies and software, allowing clients to maintain precise control over their water usage and quality, further embedding Organo's systems at the heart of their operations. Revenue flows into Organo Corp. through a diversified yet synergistic stream. By providing proprietary systems and ongoing maintenance contracts, the company ensures a steady income from the sale of equipment and services. These core offerings are supplemented by consulting and engineering services, which help clients design customized water solutions and transition seamlessly into implementation. Long-term maintenance contracts are crucial, as they not only bolster cash flow but also enhance customer loyalty and retention. Leveraging its expertise, Organo has also expanded into leasing models, allowing clients more flexibility and access to cutting-edge technology without the heavy upfront capital investment. This combination of direct sales, services, and leasing options constructs a resilient business model that's adept at navigating economic fluctuations while fostering sustainable growth.
See Also
What is Organo Corp's Income from Continuing Operations?
Income from Continuing Operations
19.9B
JPY
Based on the financial report for Sep 30, 2024, Organo Corp's Income from Continuing Operations amounts to 19.9B JPY.
What is Organo Corp's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
57%
Over the last year, the Income from Continuing Operations growth was 62%. The average annual Income from Continuing Operations growth rates for Organo Corp have been 37% over the past three years , 23% over the past five years , and 57% over the past ten years .
You don't have any saved screeners yet
